Fgbu “national medical research center of Hematology” Ministry of health of Russia together with several regional Hematology clinics begins CHRONOS19 observational study in patients with blood system diseases and COVID-19 in Russia.
In several recent studies it was discovered that the presence of oncological diseases worsens the prognosis in patients with novel coronavirus infection COVID-19. Patients with blood diseases may have an increased risk of exposure to SARS-CoV-2 or more severe disease due to the nature of the underlying disease and specific treatment, which often suppresses the immune system.
The main objective of the study was to determine peculiarities of novel coronavirus infection COVID-19 in patients with various hematological diseases. The researchers hope that the results will allow in the near future to improve treatments for this group of patients.
The study will begin in June 2020, will include about 200 patients with blood diseases infected with virus SARS-CoV-2, and will last about one year.
The project is implemented jointly with the Fund of support of scientific researches in Oncology (Respond) and the Russian company Enrollme.ru, which gave the participants their technology platform management of clinical trials and observational studies.